A Novel Homozygous KIF1C Variant in 2 Cases of Spastic Ataxia Type 2
{{output}}
Objectives: Variants of unknown significance (VUS) pose an extensive clinical challenge. Our objective was to explore the diagnostic pipeline from symptom onset to molecular diagnosis in autosomal recessive (Spastic ataxia type 2... ...